Cite Filings / RYTM / 0000769993-25-000072

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

RHYTHM PHARMACEUTICALS, INC. Filed 2025-02-10 Acc 0000769993-25-000072

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-11 4 Chief Technical Officer sold 794 shares at an average $57.51 ($45,663)
2025-02-11 4 EVP, Head of North America sold 5,216 shares at an average $58.64 ($305,846)
2025-02-11 4 Changes in Ownership
2025-02-11 4 Changes in Ownership
2025-02-10 144 Sale of Securities
2025-02-10 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…